Journal article
Antifungal susceptibility testing of dermatophytes: Development and evaluation of an optimised broth microdilution method.
- Curatolo R Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
- Juricevic N Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
- Leong C Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
- Bosshard PP Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
- 2020-10-21
Published in:
- Mycoses. - 2020
antifungal susceptibility testing
broth microdilution
dermatophytes
dermatophytosis
susceptibility tests
terbinafine resistance
English
BACKGROUND
Dermatophytosis is one of the most common infections affecting 3%-17% of the population. Resistance to antifungals so far was not of concern in the therapeutic management. However, recent reports of terbinafine-resistant strains in several countries are worrisome making antifungal susceptibility testing inevitable.
OBJECTIVES
We aimed to develop and evaluate an optimised broth microdilution assay for antifungal drug susceptibility testing of dermatophytes.
METHODS
We first studied the effect of different inocula, incubation temperatures and incubation times to establish an optimised assay. Subsequently, we tested 79 clinical strains of 11 dermatophyte species with 13 antifungals.
RESULTS
We found inoculating with 0.5-5 × 104 colony forming units (CFU) and incubating at 29°C ± 1°C for 4 days to be appropriate. Terbinafine was the most active antifungal agent with minimum inhibitory concentration (MIC) values ≤ 0.06 µg/mL, expect for one resistant T mentagrophytes strain, which was isolated from an Indian patient. Also, a majority of MICs of other antifungals that are commonly used to treat dermatophytosis were low, except those of fluconazole. Fluconazole MICs do not correlate with the good efficacy in the clinical management.
CONCLUSIONS
Our assay enables fast and reliable susceptibility testing of dermatophytes with a large panel of different antifungals. This helps to improve the therapeutic management of dermatophytosis by detecting resistant strains.
Dermatophytosis is one of the most common infections affecting 3%-17% of the population. Resistance to antifungals so far was not of concern in the therapeutic management. However, recent reports of terbinafine-resistant strains in several countries are worrisome making antifungal susceptibility testing inevitable.
OBJECTIVES
We aimed to develop and evaluate an optimised broth microdilution assay for antifungal drug susceptibility testing of dermatophytes.
METHODS
We first studied the effect of different inocula, incubation temperatures and incubation times to establish an optimised assay. Subsequently, we tested 79 clinical strains of 11 dermatophyte species with 13 antifungals.
RESULTS
We found inoculating with 0.5-5 × 104 colony forming units (CFU) and incubating at 29°C ± 1°C for 4 days to be appropriate. Terbinafine was the most active antifungal agent with minimum inhibitory concentration (MIC) values ≤ 0.06 µg/mL, expect for one resistant T mentagrophytes strain, which was isolated from an Indian patient. Also, a majority of MICs of other antifungals that are commonly used to treat dermatophytosis were low, except those of fluconazole. Fluconazole MICs do not correlate with the good efficacy in the clinical management.
CONCLUSIONS
Our assay enables fast and reliable susceptibility testing of dermatophytes with a large panel of different antifungals. This helps to improve the therapeutic management of dermatophytosis by detecting resistant strains.
- Language
-
- English
- Open access status
- closed
- Identifiers
-
- DOI 10.1111/myc.13202
- PMID 33084127
- Persistent URL
- https://sonar.ch/global/documents/82461
Statistics
Document views: 47
File downloads: